BIOA
BioAge Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.59
+0.95%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.19x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.03x
- Net debt / EBITDA
- 0.76x
Liquidity & coverage
- Current ratio
- 17.19x
- Quick ratio
- 17.19x
- Cash ratio
- 16.59x
- Interest coverage
- -378.19x
- EBITDA / interest
- -334.28x
- Working capital
- $311.1M
Cash & dividend
- FCF / debt
- -31.07x
- Cash flow / debt
- -30.90x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026